New combo therapy shows promise for prostate cancer with limited spread
NCT ID NCT02274779
First seen Feb 17, 2026 · Last updated May 07, 2026 · Updated 12 times
Summary
This study looked at 74 men with prostate cancer that had come back in up to 5 pelvic lymph nodes after initial treatment. They received high-dose radiation to the affected nodes along with hormone therapy. The goal was to see how long it would take for the cancer to progress again. The median time before relapse was measured, showing that this approach may help control the disease for a period of time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICO Paul Papin
Angers, France
-
ICO René Gauducheau
Saint-Herblain, 44800, France
Conditions
Explore the condition pages connected to this study.